Intervention

Polyphenon E

ClinicalTrials.gov intervention label

Clinical trials8

Recruiting0

Common conditions7

Lead sponsors shown6

Clinical trials

8 shown

Safety and Neuroprotective Effects of Polyphenon E in MS; Phase IINCT01451723 · 2011-07-01

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected IndividualsNCT01433289 · 2010-12-01

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in SituNCT01060345 · 2010-05-01

Safety of Polyphenon E in Multiple Sclerosis Pilot StudyNCT00836719 · 2009-02-01

Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerNCT00707252 · 2008-01-01

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaNCT00596011 · 2007-11-14

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer ProgressionNCT00676793 · 2004-05-01

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary DiseaseNCT00363805 · 2004-05-01

Common conditions

Multiple Sclerosis2 Breast Cancer1 Ductal Carcinoma in Situ1 HIV Infection1 Lung Cancer Prevention1 Non-Small Cell Lung Cancer1 Prostatic Hyperplasia1

Leading sponsors

Louisiana State University Health Sciences Center in New Orleans2 Louisiana State University Health Sciences Center Shreveport2 Baylor College of Medicine1 H. Lee Moffitt Cancer Center and Research Institute1 Sherry Chow1 University of Chicago1

Trial status mix

COMPLETED5

TERMINATED3

Phase mix

PHASE25

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.